Cumberland Pharmaceuticals (CPIX) Equity Income (2026)
Cumberland Pharmaceuticals' Equity Income came in at -$146,080 for Q1 2026.
Powered by 
Analysis
Cumberland Pharmaceuticals (CPIX) Equity Income (2026) Analysis & Trends
For FY2025, Cumberland Pharmaceuticals' Equity Income was -$13,220.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.17 Bn | 1,102.76 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 615.84 Bn | 534.36 Bn | 17.26 Bn | - |
| 3 | AbbVie | 500.69 Bn | 473.80 Bn | 12.70 Bn | - |
| 4 | Merck | 367.34 Bn | 321.72 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 297.61 Bn | 261.60 Bn | 11.24 Bn | -2.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.75 Bn | 12.86 Bn | -10.00 Mn |
| 7 | Amgen | 235.51 Bn | 190.91 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 190.60 Bn | 164.80 Bn | 6.22 Bn | - |
| 9 | Pfizer | 169.37 Bn | 116.02 Bn | 10.94 Bn | - |
| 10 | Cumberland Pharmaceuticals | 124.80 Mn | 83.29 Mn | - | - |
API Access
Cumberland Pharmaceuticals Equity Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=equity-income&ticker=CPIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "equity-income", "ticker": "CPIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=equity-income&ticker=CPIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();